Table 3 Adverse events by CTCAE grade

Overall cohort

Number, %

Experienced ≥1 adverse event

19 (29)

Hypotension

3 (5)

 Grade I

0 (0)

 Grade II

3 (5)

 Required fluid bolus

2 (3)

Bradycardia

5 (8)

 Grade I

4 (6)

 Grade II

1 (2)

Elevated AST/ALT

13 (22)

 Grade I

12 (20)

 Grade II

1 (2)

Ventricular arrhythmia

1 (2)

 Grade I

0 (0)

 Grade II

1 (2)

Mild/moderate COVID-19, high-risk for severe disease

Result

Experienced ≥1 adverse event

6 (27)